All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY0062 | Anti-ECE1 (ECE-6) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | ECE-6 | Human | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0063 | Anti-ECE1 (B61) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | B61 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0064 | Anti-ECE1 (CBFYE-0401) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-0401 | Rat | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY0065 | Anti-ECE1 (CBFYE-0402) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-0402 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3315 | Anti-ECE1 (ECE-6) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | ECE-6 | Human | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3316 | Anti-ECE1 (B61) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | B61 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3317 | Anti-ECE1 (CBFYE-0401) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-0401 | Rat | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY3318 | Anti-ECE1 (CBFYE-0402) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYE-0402 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION